PSEUDOMONAS AERUGINOSA
Clinical trials for PSEUDOMONAS AERUGINOSA explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled therapy targets tough lung infections in cystic fibrosis
Disease control Recruiting nowThis study tests an inhaled drug called RSP-1502 in people with cystic fibrosis who have a chronic lung infection caused by Pseudomonas aeruginosa bacteria. The main goal is to see if the drug is safe and how the body handles it. About 72 participants aged 12 and older will recei…
Matched conditions: PSEUDOMONAS AERUGINOSA
Phase: PHASE1, PHASE2 • Sponsor: Respirion Pharmaceuticals Pty Ltd • Aim: Disease control
Last updated May 26, 2026 04:46 UTC
-
New study aims to find best antibiotic for drug-resistant superbug infections
Disease control Recruiting nowThis study looks at 600 adults with infections caused by a hard-to-treat bacteria called Pseudomonas aeruginosa. Researchers want to see which antibiotic works best to cure the infection and prevent it from coming back. The goal is to improve treatment for people with these stubb…
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Scientists hunt for Superbug-Fighting antibodies in Patients' blood
Knowledge-focused Recruiting nowThis study looks at blood samples from 30 people who have had a Pseudomonas aeruginosa infection to find and create special antibodies that could attack this bacteria. The goal is to develop a new treatment for infections that are resistant to many antibiotics. Participants give …
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC
-
Gut germs turn deadly in ICU: scientists watch them change
Knowledge-focused Recruiting nowThis study looks at why a common gut bacterium, Pseudomonas aeruginosa, becomes deadly in critically ill patients. Researchers will collect stool samples from 100 ICU patients to see how the gut environment triggers the bacteria to turn on their virulence genes. The goal is to un…
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC